Salinisporamycin, a novel metabolite from salinispora arenicora

38Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A new rifamycin antibiotic, salinisporamycin (1), has been isolated from a culture of a marine actinomycete. The producing organism was identified as Salinispora arenicora on the basis of the 16S rRNA sequence. High-resolution FAB-MS established the molecular formula of 1 as C 33 H 43 NO 9. The planar structure of 1 was elucidated by NMR spectral analysis including COSY, heteronuclear single quantum coherence and heteronuclear multiple bond correlation. The relative stereochemistry of 1 was determined on the basis of rotating frame nuclear Overhauser effect spectroscopy. In addition, the solvatochromic behavior of 1 was investigated by measuring the UV spectra. This compound inhibited the growth of A549 cells, the human lung adenocarcinoma cell line, with an IC 50 value of 3 g ml 1, and also showed antimicrobial activity. © 2009 Japan Antibiotics Research Association All rights reserved.

Cite

CITATION STYLE

APA

Matsuda, S., Adachi, K., Matsuo, Y., Nukina, M., & Shizuri, Y. (2009). Salinisporamycin, a novel metabolite from salinispora arenicora. Journal of Antibiotics, 62(9), 519–526. https://doi.org/10.1038/ja.2009.75

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free